MARY DAVIS: Open Payments
NPI 1588856629 · VICTORIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 50 payments from 20 companies in 2025. Trend: 2023 $1,166 · 2024 $1,161 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $178 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $109 |
| SHIELD THERAPEUTICS INC | 2 | $71 |
| PFIZER INC. | 4 | $65 |
| Abbott Laboratories | 3 | $62 |
| Radius Health, Inc. | 2 | $60 |
| ABBVIE INC. | 3 | $50 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
Products named: LEQVIO, TRINTELLIX, Ozempic, ACCRUFER, FREESTYLE LIBRE 3, Tymlos, Wegovy, MOUNJARO.
Industry payments across VA — which companies pay providers there.
